Log In
Print
BCIQ
Print
Print this Print this
 

UFT

Also known as: Orzel, tegafur/uracil

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionCombination therapy of tegafur plus uracil
Molecular Target Thymidylate synthase
Mechanism of ActionThymidylate synthase inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationColorectal cancer
Indication DetailsTreat first-line metastatic colorectal cancer (mCRC)
Regulatory Designation

Partner

Merck KGaA


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today